ESTRO 2024 - Abstract Book

S5653

RTT - Patient experience and quality of life

ESTRO 2024

Conclusion:

It is both feasible and the right thing to do, to engage with and collaborate with our patients when designing and implementing research projects. The perspective of those who have the lived experience can identify what is practicable and acceptable to patients.

Providing opportunities for patients to influence study design and delivery could mitigate potential barriers to allow for optimal recruitment to a study.

Keywords: Lung cancer, Prehabilitation, radiotherapy

References:

1. Skovlund PC, Nielsen BK, Thaysen HV, et al. The impact of patient involvement in research: a case study of the planning, conduct and dissemination of a clinical, controlled trial. Res Involv Engagem 2020; 6: 43. 2. National Institute of Health and Care Excellence. Patient experience in adult NHS services: Improving the experience of care for people using adult NHS services CG138. 2012. https://www.nice.org.uk/guidance/cg138 (accessed 01.02.2019 2019). 3. Twyman L, Bonevski B, Paul C, Bryant J. Perceived barriers to smoking cessation in selected vulnerable groups: a systematic review of the qualitative and quantitative literature. BMJ Open 2014; 4(12): e006414. 4. Blaney J, Lowe-Strong A, Rankin J, Campbell A, Allen J, Gracey J. The Cancer Rehabilitation Journey: Barriers to and Facilitators of Exercise Among Patients With Cancer-Related Fatigue. Physical Therapy 2010; 90(8): 1135 - 47. 5. Murray P, Franks K, Hanna GG. A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer. Br J Radiol 2017; 90(1071): 20160732. 6. Chaudhuri AA, Chen K, Diehn M, Loo Jr BW. Stereotactic ablative radiotherapy for central and ultra-central lung tumors. Therapeutic Radiology and Oncology 2019; 3: 18-. 7. Snee MP, McParland L, Collinson F, et al. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection. Pilot Feasibility Stud 2016; 2: 5. 8. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Impact of comorbidity on lung cancer survival. Int J Cancer 2003; 103(6): 792-802. 9. De Silva MJ, Breuer E, Lee L, et al. Theory of Change: a theory-driven approach to enhance the Medical Research Council's framework for complex interventions. Trials 2014; 15(267).

945

Digital Poster

Addressing health and racial disparity in women with breast cancer: Black Women Rising Charity.

Leanne Pero 1 , Olivia Lond-Caulk 1 , Jo McNamara 2 , Naman Julka-Anderson 2

1 Black Women Rising Charity, Black Women Rising Charity, London, United Kingdom. 2 Rad Chat, Oncology Podcast, Sheffield, United Kingdom